National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

acridine carboxamide
A tricyclic acridine-based (or carboxamide-based) drug with dual topoisomerase inhibitor and potential antineoplastic activities. Acridine carboxamide inhibits both topoisomerases I and II and intercalates into DNA, resulting in DNA damage, the disruption of DNA repair and replication, the inhibition of RNA and protein synthesis, and cell death. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Abbreviation:DACA
Code name:XR5000



Previous:acivicin, aclarubicin, Acnestrol, ACNU 50, acodazole
Next:ActHIB, Actigall, Actimmune, Actinex, Actiq

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov